Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cantaloupe (CTLPP) Research & Development (2020 - 2026)

Cantaloupe has reported Research & Development over the past 6 years, most recently at $4.6 million for Q4 2025.

  • Quarterly Research & Development rose 2.17% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.1 million through Dec 2025, down 1.6% year-over-year, with the annual reading at $17.4 million for FY2025, 5.55% up from the prior year.
  • Research & Development was $4.6 million for Q4 2025 at Cantaloupe, down from $5.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $6.9 million in Q3 2022 and troughed at $3.0 million in Q4 2023.
  • The 5-year median for Research & Development is $4.6 million (2023), against an average of $4.8 million.
  • Year-over-year, Research & Development soared 67.67% in 2021 and then plummeted 42.82% in 2023.
  • A 5-year view of Research & Development shows it stood at $5.8 million in 2021, then dropped by 8.32% to $5.3 million in 2022, then plummeted by 42.82% to $3.0 million in 2023, then soared by 49.27% to $4.5 million in 2024, then grew by 2.17% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for CTLPP's Research & Development are $4.6 million (Q4 2025), $5.0 million (Q3 2025), and $4.1 million (Q2 2025).